1Speroff L, Glass RH, Kase NG. Clinical Gynecologic Endocrinology and Infertility.(Sixthedition). Philadephia, PA 19106, Baltinore,Narghland: Lippincott Williams and Wikins. 1999, 211-224.
2Welt C, Sidis Y, Keutmann H, et al. Activins, inhibins, and follistatins:from endocrinology to signaling. A paradigm for the new millennium.Exp Biol Med (Maywood) ,2002, 27(9): 724-752.
3Fischer WH, Park M, Donaldson C, et al. Residues in the C-terminal region of Activin A determine specificity for follistatin and type Ⅱ receptor binding. J Endocrinol, 2003,176(1):61-68.
4Bilezikjian LM, Leal AM, Blount AL, et al. Rat anterior pituitary folliculostellate cells are targets of interleukin-1beta and a major source of intrapituitary follistatin. Endocrinology, 2003,144(2):732-740.
5Bartholin L, Maguer-Satta V, Hayette S, et al. Transcription activation of FLRG and follistatin by activin A, through smad proteins, participates in a negative feedback loop to modulate Activin A function.Oncogene, 2002,21(14):2227-2235.
6Chong H, Pangas SA, Bernard DJ, et al. Structure and expression of a membrane component of the inhibin receptor system. Endocrinology,2000,141(7): 2600-2607.
7Martin MM. In Search of binding-identification of inhibin receptors.Endocrinology, 2000,141(7):2281-2284.
8Welt CK. The physiology and pathophysiology of inhibin, activin and follistatin in female reproduction. Curr Opin Obstet Gynecol, 2002,14(3):317-323.
9Chapman SC, Woodruff TK.Modulation of activin signal transduction by inhibin B and inhibin-binding protein (INhBP).Mol Endocrinol,2001,15(4):668-679.
10Lewis KA, Gray PC, Blount AL, et al. Betaglycan binds inhibin and can mediate functional antagonism of Activin signaling. Nature,2000,404(6776):411-414.
